UNIVERSE PHARMACEUTICAL-CL A (UPC) Stock Price, Forecast & Analysis

NASDAQ:UPC • KYG9442G1385

2.68 USD
-0.18 (-6.29%)
Last: Feb 17, 2026, 04:30 PM

UPC Key Statistics, Chart & Performance

Key Statistics
Market Cap1.50M
Revenue(TTM)17.86M
Net Income(TTM)-3.67M
Shares560.00K
Float560.00K
52 Week High11
52 Week Low2.51
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-10.13
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2021-03-23
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
UPC short term performance overview.The bars show the price performance of UPC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40

UPC long term performance overview.The bars show the price performance of UPC in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of UPC is 2.68 USD. In the past month the price decreased by -40.58%. In the past year, price decreased by -66.73%.

UNIVERSE PHARMACEUTICAL-CL A / UPC Daily stock chart

UPC Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
UPC Full Technical Analysis Report

UPC Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to UPC. The financial health of UPC is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
UPC Full Fundamental Analysis Report

UPC Financial Highlights

Over the last trailing twelve months UPC reported a non-GAAP Earnings per Share(EPS) of -10.13. The EPS increased by 99.48% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -5.3%
ROE -6.54%
Debt/Equity 0.13
Chartmill High Growth Momentum
EPS Q2Q%-100.34%
Sales Q2Q%-14.14%
EPS 1Y (TTM)99.48%
Revenue 1Y (TTM)-22.44%
UPC financials

UPC Forecast & Estimates


Analysts
Analysts0
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
UPC Analyst EstimatesUPC Analyst Ratings

UPC Ownership

Ownership
Inst Owners0.36%
Ins OwnersN/A
Short Float %2.09%
Short Ratio0.11
UPC Ownership

UPC Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
LLY ELI LILLY & CO30.87983.195B
JNJ JOHNSON & JOHNSON20.89586.544B
MRK MERCK & CO. INC.22.47301.342B
PFE PFIZER INC9.11156.812B
BMY BRISTOL-MYERS SQUIBB CO9.92123.651B
ZTS ZOETIS INC18.2855.813B
RPRX ROYALTY PHARMA PLC- CL A8.7526.086B
VTRS VIATRIS INC6.2218.163B
ELAN ELANCO ANIMAL HEALTH INC23.7812.486B
AXSM AXSOME THERAPEUTICS INC223.829.135B

About UPC

Company Profile

UPC logo image Universe Pharmaceuticals, Inc. is a pharmaceutical company. The company is headquartered in Ji'An, Jiangxi and currently employs 225 full-time employees. The company went IPO on 2021-03-23. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The firm mainly conducts its businesses within the Chinese market.

Company Info

UNIVERSE PHARMACEUTICAL-CL A

265 Jingjiu Avenue, Jinggangshan Econ. And Tech. Dev. Zone

Ji'an JIANGXI CN

Employees: 225

UPC Company Website

UPC Investor Relations

Phone: 867968403309

UNIVERSE PHARMACEUTICAL-CL A / UPC FAQ

What does UNIVERSE PHARMACEUTICAL-CL A do?

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The company is headquartered in Ji'An, Jiangxi and currently employs 225 full-time employees. The company went IPO on 2021-03-23. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The firm mainly conducts its businesses within the Chinese market.


Can you provide the latest stock price for UNIVERSE PHARMACEUTICAL-CL A?

The current stock price of UPC is 2.68 USD. The price decreased by -6.29% in the last trading session.


Does UNIVERSE PHARMACEUTICAL-CL A pay dividends?

UPC does not pay a dividend.


What is the ChartMill technical and fundamental rating of UPC stock?

UPC has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Can you provide the sector and industry classification for UNIVERSE PHARMACEUTICAL-CL A?

UNIVERSE PHARMACEUTICAL-CL A (UPC) operates in the Health Care sector and the Pharmaceuticals industry.


What is the market capitalization of UPC stock?

UNIVERSE PHARMACEUTICAL-CL A (UPC) has a market capitalization of 1.50M USD. This makes UPC a Nano Cap stock.


Who owns UNIVERSE PHARMACEUTICAL-CL A?

You can find the ownership structure of UNIVERSE PHARMACEUTICAL-CL A (UPC) on the Ownership tab.